Podcasts about fda commissioner dr

It's Wednesday, May 28th, A.D. 2025. This is The Worldview in 5 Minutes heard on 125 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark Somalian Muslim man trusts Christ and is kicked out of home A young Muslim man in Somalia was kicked out of his home recently after converting to Christianity.  The 20-year-old struggled with substance abuse and had not been home to see his Muslim parents for months. That's when an underground pastor shared the Gospel with him. The young man came to Christ and gained freedom from drug use. After going home, however, his parents drove him away because of his new faith. The young convert told Morning Star News, “Now that I have loved [Jesus], I do not have a family standing with me. I do no not know what to do. I need prayers.” Please pray for this brother in Christ in Somalia, Africa. The country is ranked second on the Open Doors' World Watch List of most difficult places to be a Christian.  In Matthew 19:29, Jesus said, “And everyone who has left houses or brothers or sisters or father or mother or wife or children or lands, for My name's sake, shall receive a hundredfold, and inherit eternal life.” French Muslim youth vandalizing Catholic churches and assaulting Catholics The European Conservative reports there have been a string of attacks on churches in France recently which have received little attention from the mainstream media. In one case, Islamic youths insulted a Catholic priest and threatened to set the church building on fire earlier this month. Days earlier, another group disrupted a parish meeting in the same area. Muslim attacks on Catholics have included vandalism, physical assault, and kidnapping. Supremes split decision result: OK religious charter school unfunded In the United States, the Supreme Court delivered a split decision last Thursday in a case involving religious education. Previously, Oklahoma's charter school board had approved funding for St. Isidore of Seville Catholic Virtual School. It would have been the country's first publicly-funded religious charter school.  However, Oklahoma's Supreme Court blocked the school. And the U.S. Supreme Court ruled 4-4 in the case, leaving the lower court ruling in place.  For some reason, conservative Justice Amy Coney Barrett recused herself from the case.  Defense Secretary Hegseth: "“King Jesus, we come humbly before You." U.S. Secretary of Defense Pete Hegseth led a prayer meeting at the Pentagon last Wednesday. Listen to his opening prayer. HEGSETH: “If you would bow your head in prayer. “King Jesus, we come humbly before You, seeking Your face, seeking Your grace, in humble obedience to your law and to Your Word. We come as sinners, saved only by that grace, seeking Your providence in our lives and in our nation. “Lord God, we ask for the wisdom to see what is right, and in each and every day, in each and every circumstance, the courage to do what is right in obedience to Your will. “It is in the name of our Lord and Savior Jesus Christ, that we pray. And all God's people said, Amen. Thank you.” The voluntary 30-minute prayer meeting was called “Secretary of Defense Christian Prayer & Worship Service.” Hegseth said it may become a monthly event.  Colossians 4:2 says, “Continue earnestly in prayer, being vigilant in it with thanksgiving.” Planned Parenthood to close 8 abortion mills in Iowa and Minnesota Last Friday, Planned Parenthood North Central States announced it will close eight locations across Iowa and Minnesota over the next year. Planned Parenthood blamed the closures on states passing anti-abortion laws as well as a freeze on federal funding for abortion. The closures will also involve laying off 66 staff members. CDC no longer recommends COVID-19 shot for pregnant women & kids The U.S. Centers for Disease Control and Prevention will no longer recommend COVID-19 shots for pregnant women and healthy children. Health and Human Services Secretary Robert F. Kennedy Jr. made the announcement yesterday. KENNEDY: “Hi everybody. I'm Robert F. Kennedy, Jr, your HHS Secretary.  And I'm here with NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty MaKary. “I couldn't be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC-recommended immunization schedule. Last year, the Biden administration urged healthy children to get yet another COVID shot, despite the lack of any clinical data to support the repeat booster strategy in children! BHATTACHARYA: “That ends today. It's common sense and it's good science.” MAKARY: “There's no evidence healthy kids need it today. And most countries have stopped recommending it for children.” KENNEDY: “We're now one step closer to realizing President Trump's promise to make America healthy again.” Lawmakers want to launch “Natural Family Month” Republican lawmakers in Ohio are considering a bill to celebrate families. The measure would designate the weeks from Mother's Day to Father's Day as “Natural Family Month.” The timeframe goes from the second Sunday in May to the third Sunday in June. This contrasts with Homosexual/Transgender Pride Month when many celebrate sexually perverted lifestyles in June. 1,500-year-old Christian graves in Israel discovered And finally, archaeologists recently uncovered 1,500-year-old Christian graves in Israel's Negev Desert. The graves reflect Christian burial practices. Inside, archaeologists found rare ebony figurines depicting individuals with African features. Researchers wrote, “It is possible that the deceased were of ‘Ethiopian' origin, and that they, or their ancestors, converted to Christianity and moved to the Negev.” The figurines were made out of ebony wood sourced from India or Sri Lanka and likely carved in Africa before being brought to the Negev.  Researchers believe it is the first time they have discovered such artifacts in the region of Israel and Jordan.  Close And that's The Worldview on this Wednesday, May 28th, in the year of our Lord 2025. Subscribe for free by Spotify, Amazon Music or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. Or get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Meet our friends, Clay Travis and Buck Sexton! If you love Verdict, the Clay Travis and Buck Sexton Show might also be in your audio wheelhouse. Politics, news analysis, and some pop culture and comedy thrown in too. Here’s a sample episode recapping four Tuesday takeaways. Give the guys a listen and then follow and subscribe wherever you get your podcasts. CDC 86's Covid Vax Hour 1 of The Clay Travis and Buck Sexton Show kicks off with Clay Travis solo-hosting as Buck Sexton recovers from the flu. Clay reflects on Memorial Day, honoring the sacrifices of American service members, and shares highlights from his visit to the Indy 500, emphasizing the strong presence of Clay and Buck listeners. The hour dives into major political and cultural topics, starting with breaking news: the CDC has officially removed the COVID-19 vaccine from its recommended immunization schedule for healthy children and pregnant women. Clay highlights this as a significant reversal of previous federal health mandates and criticizes the Biden administration and legacy media for their role in promoting what he calls “COVID shot propaganda.” He underscores the personal and professional consequences many Americans faced for refusing the vaccine, including job loss and social ostracization. Riley Gaines on Fame The long-term consequences of COVID-19 policies, the erosion of trust in public health institutions, and the ongoing controversy surrounding transgender athletes in women’s sports. Clay Travis, hosting solo, opens the hour by reacting to breaking news that the COVID-19 vaccine has been removed from the recommended list for children and pregnant women—a decision that sparks a broader conversation about government overreach, vaccine mandates, and the psychological toll of pandemic-era restrictions. Clay is joined by former NCAA swimmer and women’s sports advocate Riley Gaines, who shares her personal experiences with COVID-era mandates while competing at the University of Kentucky. Gaines recounts the extreme and often illogical protocols athletes endured, including wearing masks between swim laps and facing pressure to get vaccinated despite natural immunity. She reflects on the broader impact of school closures and social isolation on young people, emphasizing how these policies robbed students of formative life experiences. The conversation shifts to the ongoing debate over biological males competing in women’s sports. Gaines and Travis discuss recent incidents, including a viral protest by a female athlete in California and former President Donald Trump’s public condemnation of transgender participation in women’s competitions. Gaines criticizes the Democratic Party’s unwavering support for these policies and highlights the bravery of young women standing up for fairness in sports. She also addresses personal attacks from media figures like Jemele Hill and Keith Olbermann, reinforcing her commitment to advocating for women’s rights and equal opportunities. Dr. Marty Makary, FDA Commissioner Clay welcomes newly appointed FDA Commissioner Dr. Marty Makary, who, alongside Dr. Jay Bhattacharya and RFK Jr. announced the removal of the COVID shot recommendation for healthy children and pregnant women. Dr. Makary explains the need to restore scientific integrity and transparency in public health, criticizing the previous administration’s reliance on unproven theories and lack of clinical trial data. He emphasizes the importance of rebuilding trust by focusing on chronic disease prevention, food quality, and environmental health. Dr. Makary also reflects on the failures of school closures, the disproportionate impact on low-income and minority communities, and the long-term mental health consequences for children. He calls for a renewed commitment to evidence-based medicine and civil discourse, warning against the dangers of censorship and politicization in science. President Trump Endorses Clay's New Book! the Democratic Party’s struggle to connect with young male voters, the cultural alienation of boys, and the broader implications for American society and politics. Clay opens the hour by discussing a recent New York Times article detailing a $20 million Democratic initiative—codenamed SAM (Speaking with American Men)—aimed at reversing the party’s declining support among young men. He critiques the effort as tone-deaf and disconnected from the realities of modern masculinity, drawing parallels to themes in his upcoming book, Balls: How Trump, Young Men, and Sports Saved America, which has been endorsed by former President Donald Trump. Throughout the segment, Clay shares personal anecdotes and cultural observations that highlight the erosion of male identity in contemporary America. He recounts a moment with his son in a Target store, where the overwhelming presence of “girl power” messaging sparked a realization about the lack of positive male representation. He also discusses the impact of COVID-19 lockdowns on boys, particularly the cancellation of sports and school activities, which he argues contributed to a growing sense of disenfranchisement among young men. Make sure you never miss a second of the show by subscribing to the Clay Travis & Buck Sexton show podcast wherever you get your podcasts! ihr.fm/3InlkL8 For the latest updates from Clay and Buck: https://www.clayandbuck.com/ Connect with Clay Travis and Buck Sexton on Social Media: X - https://x.com/clayandbuck FB - https://www.facebook.com/ClayandBuck/ IG - https://www.instagram.com/clayandbuck/ YouTube - https://www.youtube.com/c/clayandbuck Rumble - https://rumble.com/c/ClayandBuck TikTok - https://www.tiktok.com/@clayandbuck YouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.

Katelyn and Abdul break down the latest news in public health and policy, including: RFK's appearance at the House Appropriations Committee and the Senate Health Committee The House budget proposal to cut Medicaid Donald Trump's Executive Order to bring down drug prices Trump's nominee for Surgeon General Then Abdul interviews former FDA Commissioner Dr. David Kessler about his new book Diet, Drugs and Dopamine. Check out our shop at store.americadissected.com for our new America Dissected merch – including logo shirts, hoodies and mugs. And don't miss our “Vaccines Matter. Science Works.” t-shirts! This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: de Beaumont Foundation: For 25 years, the de Beaumont Foundation has worked to create practical solutions that improve the health of communities across the country. To learn more, visit debeaumont.org.  Lumen: Go to lumen.me/AD to get 15% off your Lumen. Our Big Shot: Search for and subscribe to “Our Big Shot: Wiping Out Disease” on Apple Podcasts, or your favorite podcast app.

Lower Costs, Bigger Wins, Interviews with FDA Commissioner Dr. Makary & Reporter Luke Rosiak | TRIGGERED Ep.240 Live from Rumble Studio Just visit http://allfamilypharmacy.com/DONJR and use code DONJR10 for 10% off your order. --- Tell Congress to End the Biden Pill Penalty:Go To www.Seniors4BetterCare.com --- Visit http://www.Byrna.com/DonJR to receive 10% off the curated Byrna bundles! Learn more about your ad choices. Visit megaphone.fm/adchoices

Drug prices will be going down, FDA Commissioner Dr. Marty Makary agrees it is time, and drug company reps are no longer welcome on advisory committees. RFK Jr. is leading the way on research to discover the cause of autism, which is also connected to the transgender movement. We connect the dots with stories from the US and the UK.

A Note from James:Marty Makary is the new head of the FDA, but he is also an old friend of the podcast. He's been on several times, and it's really important to know how this is going to be a new and different FDA, and it's going to be molded by Marty's very specific opinions about healthcare and the medical industry—and here they are.Episode Description:In this episode, James reconnects with Dr. Marty Makary, now heading the FDA, to discuss what's broken in the American healthcare system—and what can actually be done about it. Marty pulls back the curtain on the realities of medical pricing, why unnecessary surgeries happen more often than most suspect, and how medical education is failing future doctors and patients alike. They explore the origins of Marty's bestselling books, the TV adaptation of Unaccountable, and why your hospital bill may have little to do with actual care. This conversation is a rare window into what's really happening inside hospitals and policy rooms—and what the future of smarter, more humane healthcare could look like.What You'll Learn:Why 11% of surgeries and 21% of all medical care may be unnecessary—and what's driving that trend.How hidden costs, out-of-network billing, and surprise charges are crippling Americans financially.What reforms are gaining traction in Congress and why hospitals may be resisting them.How nutrition, inflammation, and simple wellness practices are overlooked in modern medicine.What questions you should ask your doctor to avoid inappropriate or excessive care.Timestamped Chapters:[00:00] Introduction to Marty Makary and the New FDA[01:17] From Book to TV Show: The Journey of Unaccountable[03:42] The Price We Pay: Unveiling Healthcare Costs[09:06] Medical Education and Its Flaws[15:01] The Hidden Costs of Healthcare[34:52] Inappropriate Care and Its Consequences[43:14] The Referral Business in Medicine[44:00] Unnecessary Surgeries: A National Concern[44:48] Malpractice Fears and Their Impact[47:33] The Overuse of Antibiotics[50:28] Inappropriate Medical Care: Real-Life Examples[53:45] The Role of Nutrition and Wellness in Healthcare[58:15] Innovative Medical Education and Training[01:00:36] The Importance of Experience in Medical Practice[01:18:32] The Future of Healthcare: Inflammation and Biome Health[01:20:53] Final Thoughts and Practical Health TipsAdditional Resources:Dr. Marty Makary's websiteUnaccountable by Marty MakaryThe Price We Pay by Marty MakaryThe Resident (TV Series)Healthcare BluebookRestoring MedicineSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Historic moves out of Washington D.C., as HHS Secretary Robert F. Kennedy Jr. announces his fight to find the cause of autism, and new FDA Commissioner Dr. Marty Makary takes action to remove toxic additives and dyes from our food. Jefferey Jaxen reports on the White House embracing lab leak theory, the bleak future of Bayer's Roundup, and new cancer risks associated with COVID vaccines—just as the federal government begins to reverse its stance. New Bill Makes Health History in Tennessee. Finally, retired pediatrician Dr. Paul Thomas shares his journey from vaccine advocate to whistleblower in his new book, ‘Vax Facts.'Guests: Bernadette Pajer, Dr. Paul Thomas#TheHighWire #RFKJr #MartyMakary #FoodDyeBan #VaccineSafety #COVIDVaccine #AutismAwareness #PaulThomasMD #Glyphosate #Roundup #HealthFreedom #LabLeakBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Megyn Kelly is joined by FDA Commissioner Dr. Marty Makary for his first interview in his new position to discuss what he's learned since taking over the position 17 days ago, whether there are people in the building who are open to MAHA, what's currently working properly at the agency and what's not, the issues with the VAERS system, recent critiques from Peter Marks who left the agency, the need to ask questions in science and not jump to conclusions, his new policy limiting who can serve as members on FDA advisory committees, his efforts to counter the perception that the FDA has been captured by Big Pharma and other industries, how he learned first-hand about "the swamp," the apolitical work he and RFK are doing, his efforts to get certain drugs approved faster and to limit animal testing, the truth about the DOGE cuts and how no scientists or reviewers were cut, his relationship with RFK, his effort to redo the food pyramid, the efforts by RFK to get to the cause of autism, the need to look at environmental and dietary exposures that could alter the microbiome, and more. Grand Canyon University: https://GCU.eduLean: Visit https://TakeLean.com & use code MK20 for 20% offAncient Nutrition: Enjoy 25% off your first order at https://AncientNutrition.com/MEGYNFollow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at: https://www.devilmaycaremedia.com/megynkellyshow

About this episode: Last week, the Department of Health and Human Services abruptly fired around 10,000 employees, 3,500 of which were within the FDA alone—an organization of around 18,000 total employees as of January 2025. In this episode: A look at the work of the FDA and how it may be hampered by such significant cuts, and how patients may be among those most impacted. Guest: Dr. Robert Califf served as the FDA Commissioner under Presidents Barack Obama and Joe Biden. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Dr. Peter Marks's Resignation Letter (PDF)—The New York Times Widespread firings start at federal health agencies including many in leadership—NPR Shots The U.S. Food Safety System—Public Health On Call (June 2022) FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust—Public Health On Call (August 2022) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Happy New Year! 2025 brings executive turnover to multiple corporate teams, including Apple, which is replacing its CFO, and Disney, where Morgan Stanley's James Gorman is helping find a successor to Bob Iger. Dartmouth Tuck School of Business professor Paul Argenti weighs the succession plans at both companies. And this January, we're in the thick of cold, flu, RSV, and norovirus; former FDA Commissioner Dr. Scott Gottlieb discusses the uptick in illness this winter, as well as potential changes to the U.S. healthcare system. Plus, New York's congestion pricing looms, and deadly incidents in New Orleans and Las Vegas prompted security concerns on New Year's Day. Scott Gottlieb - 13:26Paul Argenti - 25:32 In this episode:Becky Quick, @BeckyQuickJoe Kernen, @JoeSquawkKatie Kramer, @Kramer_Katie

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viral vector manufacturers are facing challenges such as high production expenses, low titers, empty capsids, and limited scalability when producing cell and gene therapies. To overcome these challenges, they are turning to next generation production processes to create a cost-effective and robust AAV manufacturing process. This new approach aims to produce higher titers and full capsids, increase efficiencies resulting from high yields, and drive down the cost per dose. By implementing these strategies, manufacturers can improve the productivity of AAV production and bring promising treatments to the market more effectively.Embecta received FDA approval for its insulin patch pump, featuring a larger insulin reservoir based on feedback from people with type 2 diabetes. Meanwhile, Illumina avoided a fine for its acquisition of Grail in a European court victory. The ARPA-H program will focus on AI degradation in medical tools, while a pathology group is suing to block an FDA lab test rule. Additionally, Medtronic's chief medical officer of acute care and monitoring has departed for a new role.The text discusses various updates in the biopharma industry as of September 3, 2024. It covers topics such as the next challenger to Prevner, advancements in AI drug discovery, concerns over suicide risk of obesity drugs, Recursion's lead drug safety, Vaxcyte's positive data for a pneumococcal vaccine, Sanofi's mixed results in MS drug trials, and the value of digital insights in pharma success.A new study predicts a healthcare labor shortage by 2028, with certain states and specialties facing acute shortages. The study also reveals disparities in fighting medical bills, as uninsured and less educated patients are less likely to question their bills. The ARPA-H program will focus on addressing AI degradation in medical tools. Other updates include tracking healthcare worker strikes and data breaches. The use of technology is transforming healthcare to combat challenges such as workforce shortages and shifting care utilization patterns.FDA Commissioner Dr. Robert Califf is considering reforms to advisory committees, including potentially scrapping expert voting in some circumstances. Califf believes that the discussions within these committees may be more valuable to the FDA than the final vote outcomes. Eliminating voting could help clarify the role of advisory committees. Other potential reforms being discussed include addressing conflicts of interest.The text discusses the importance of getting the Institutional Review Board (IRB) review right the first time and introduces a checklist of critical questions to ask potential IRB partners to ensure a smoother review process. By asking the right questions and choosing the right IRB, the review process can be more efficient and effective.Novo Nordisk's drug Ozempic will continue to face shortages into the fourth quarter due to supply issues, even as the company tries to expand its indication. Astellas Gene Therapies is closing its biomanufacturing facility in San Francisco, affecting about 100 employees and shifting manufacturing to North Carolina.In a landscape where consumers are willing to switch brands to save money, it is crucial for brands to establish and maintain loyalty among shoppers. By leading with value, moving consumers from awareness to loyalty to advocacy, and creating connection and community, brands can build brand love even in the face of economic pressures.The text discusses how emerging oncology innovations have led to more effective therapies for cancer patients. The increased investment in cancer research has introduced new treatments such as cell and gene therapies, antibody drug conjugates, and checkpoint inhibitors. Despite these advancements, the industry still faces challenges in expanding access and improving outcomes.

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-1 medication is launched, a new company tauts and all-in-one sensor and pump infusion set, a new diabetes accessory in the Roblox game, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX The first ever generic GLP-1 medication will soon be available in the US. It's a generic of Victoza, originally approved by the FDA in 2010 for diabetes, is part of the same class of drugs that includes Ozempic and Mounjaro. Liraglutide is Glucagon-like peptide-1 receptor agonists (otherwise known as GLP-1s or GLP-1 RAs) are a class of incretin drugs that mimic the body's natural hormones to help treat diabetes and obesity. However, the popularity of the drugs has spiraled out of control at times, leading to shortages and supply chain issues in the US and abroad.  The arrival of a GLP-1 generic drug provides reasons to be hopeful for doctors and patients alike, but there are also caveats. Couple of caveats - liraglutide is injected once daily (vs. weekly) and many doctors say it doesn't work as well for as many people as semaglutide and terzepatide. No confirmation on the price Two other generic options are being developed and could launch in December 2024. Patents for newer GLP-1 medications like Ozempic and Wegovy won't expire until several years down the road https://www.healthline.com/health-news/victoza-generic-glp1-drug-available XX Senseonics plans to launch a 365-day sensor in the U.S. in the fourth quarter of this year. A one-year Eversense CGM could be a game changer for the company.   In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current 180-day version of Senseonics' implantable Eversense CGM. Eversense's 180-day sensor can need calibrating twice a day, something Senseonics CEO Tim Goodnow said “has been a competitive disadvantage.” Users calibrate the 365-day sensor once a week. Senseonics is in talks with insulin pump manufacturers about integrating its Eversense CGM with their devices but has yet to commit to a timeline for finalizing an agreement. https://www.medtechdive.com/news/senseonics-365-day-cgm-2025-sales/719717/ XX People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn't deter patients from using the medicines to treat diabetes or obesity.   Last summer, doctors at Mass Eye and Ear noticed an unusually high number of patients with non-arteritic anterior ischemic optic neuropathy, or NAION, a type of eye stroke that causes sudden, painless vision loss in one eye.   The condition is relatively rare — up to 10 out of 100,000 people in the general population may experience it — but the doctors noted three cases in one week, and each of those patients was taking semaglutide medications. The risk was found to be greatest within the first year of receiving a prescription for semaglutide.   The study, published Wednesday in the medical journal JAMA Ophthalmology, cannot prove that semaglutide medications cause NAION. And the small number of patients — an average of about 100 cases were identified each year — from one specialized medical center may not apply to a broader population. The ways that semaglutides interact with the eyes are not entirely understood. And the exact cause of NAION is not known either. The condition causes damage to the optic nerve, but there is often no warning before vision loss.   For now, patients who are taking semaglutide or considering treatment should discuss the risks and benefits with their doctors, especially those who have other known optic nerve problems such as glaucoma or preexisting visual loss, experts say https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-ozempic-linked-with-sight-threatening-eye-disorder-study-2024-07-03/ XX We got some updates at ADA about the over the counter CGMS Dexcom Stelo and Abbot's Libre. Dexom plans a late august launch of stelo, which you'll order from their website – it won't be physically in stores. Abbott also plans to sell its wellness-oriented Lingo device this summer through an e-commerce website. That's a sensor that's been available in other coutnires for a while, but was recently okayed in the US. It's not meant for people with diabetes. The Libre Rio is designed or adulst with type 2 who don't use insulin. No timing yet on that product's launch. Neither Abbott nor Dexcom have disclosed pricing for the upcoming products. https://www.medtechdive.com/news/abbott-dexcom-over-the-counter-cgm-launch/719928/ XX Insulet is looking to expand the label for its Omnipod 5 insulin pump for people with Type 2 diabetes. The company said Friday it recently filed with the Food and Drug Administration. Insulet presented study results at the American Diabetes Association's 84th Scientific Sessions that evaluated Omnipod 5 in people with Type 2 diabetes who were taking basal insulin or multiple daily injections. The results showed “substantial improvements in blood glucose outcomes and overall quality of life,” said study chair Francisco Pasquel, an associate professor of endocrinology at Emory School of Medicine. Omnipod 5 is currently cleared in the U.S. for people with Type 1 diabetes. Insulet hopes to expand the pump to people with Type 2 diabetes, with an expected launch in early 2025. The FDA has not yet cleared any automated insulin delivery systems for people with Type 2 diabetes, Insulet said. The company has a basal-only insulin pump, called Omnipod Go, that was cleared for people with Type 2 diabetes last year, but it does not connect to other devices. Even though Omnipod 5 is not currently indicated for Type 2 diabetes, doctors prescribe it for their patients with full reimbursement since the pharmacy channel doesn't distinguish between Type 1 or Type 2 patients, J.P. Morgan analyst Robbie Marcus wrote in a research note on Sunday. https://www.medtechdive.com/news/insulet-omnipod-5-type-2-diabetes-study/719644/ XX In the keynote address at the American Diabetes Association annual conference, FDA Commissioner Dr. Robert Califf expressed concerns about the rising rates of diabetes in the U.S. Though revolutionary medications and technologies for diabetes and weight loss continue to emerge, these treatments are vastly underused. The silver lining lies with type 1 diabetes therapies, which are showing great promise in clinical trials. “For the larger epidemic of type 2 diabetes, we're failing right now,” Califf said. “I don't say that lightly.” A huge problem, Califf said, is access. While most health insurance plans cover medical devices and medications for diabetes, without insurance, costs add up quickly. Ozempic, for example, costs nearly $1,000 per month without insurance. Studies have found that regardless of insurance status, roughly 26% of Americans skipped or delayed treatment due to cost. https://diatribe.org/diabetes-management/fda-commissioner-says-were-failing-people-type-2-diabetes XX Embecta presented two abstracts at the American Diabetes Association Scientific Sessions last weekend making the case for its insulin patch pump for Type 2 diabetes. The company submitted the device for Food and Drug Administration clearance in late 2023. The diabetes device company developed a patch pump with a larger insulin reservoir that can hold up to 300 units. Embecta, which is better known for making equipment such as pen needles and insulin syringes, has been developing its first patch pump. The company found that a device with a larger insulin reservoir could provide longer wear times and fewer disposable patches. https://www.medtechdive.com/news/embecta-insulin-patch-pump-volume-american-diabetes-association/719779/ XX   Pump/CGM sensor in one The niaa signature patch pump, shown with a watch displaying current blood sugar level The niaa signature patch pump has a manual bolus button and is part of an in-development AID system. Swiss technology maker Pharmasens demonstrated a new semi-reusable tubeless patch pump and glucose sensor in the same compact device, called the niia signature, which the company says can be worn for five days.   The top of the device, which includes Bluetooth connectivity and the electronic and mechanical parts to control the pump, separates from the disposable 300-unit reservoir along with the adhesive used to attach the device to the body via a steel cannula. A small button on the device allows manual bolusing. The company says an AID system will manage the device, controlled by smartphone.   PharmaSens' simpler basal-bolus patch pump, the niia essential, was submitted for FDA approval in late December. Availability of the niia signature AID system has yet to be announced. https://diatribe.org/diabetes-technology/diabetes-technology-display-ada-2024 XX Edgepark Commercial XX New international consensus statement offers guidance on the care and monitoring of people who are at high risk for type 1 diabetes (T1D). This is all about screening and testing for islet autoantibodies. These individuals are classified as: At risk or Stage 0 (single autoantibody or transient single autoantibody), Stage 1 (two or more autoantibodies with normoglycemia), and Stage 2 (two or more autoantibodies with dysglycemia but without symptoms and not yet meeting diagnostic criteria for Stage 3 clinical T1D). The document was presented on June 24, 2024 in a 90-minute symposium at the American Diabetes Association's annual Scientific Sessions and published simultaneously in both Diabetes Care and Diabetologia. "This is not guidance around who to screen or when to screen. This is guidance for the hundreds of thousands of people around the world who have participated in screening, mostly through research programs, and have been identified with positive autoantibodies and need care in the clinical setting," panel co-chair Anastasia Albanese-O'Neill, PhD, APRN, CDCES, of Breakthrough T1D, told Medscape Medical News.   The recommendations also include when to start insulin, and how to provide education and psychosocial support to individuals and family members of those given the early-stage T1D diagnosis. https://www.medscape.com/viewarticle/experts-advise-early-risk-monitoring-type-1-diabetes-2024a1000bpo XX Roblox has added a diabetic option, complete with insuli pen and Dexcom You can find it in the marketplace JDRF – now breakthrough t1d – started a world in roblox a couple of years ago as well Roblox is a super popular online game that a lot of kids play. https://www.roblox.com/games/5823990610/Breakthrough-T1D-World XX FFL next week! Join us again soon!

Senator Elizabeth Warren (D-MA) is taking on big banks and Federal Reserve Chair Jay Powell, to whom she says, “do your job.” She has a spirited conversation with Becky Quick and Joe Kernen about the Fed, the banking system, and tax code fairness. And after the Surgeon General's warning on social media's harm to kids, former FDA Commissioner Dr. Scott Gottlieb discusses the science proving social media's toll on teens, and he compares Congress's strategy today with the FDA's strategy navigating illicit opioid sales on social media, years ago. Plus, CNBC's Emily Wilkins reports on the boom of “revenge porn” deepfakes, Apple will stop offering buy now, pay later loans in the U.S., and some victims of the AI craze: Chegg stock is down 90% since OpenAI's launch of ChatGPT.  Sen. Elizabeth Warren - 10:36Dr. Scott Gottlieb - 28:26 In this episode:Sen. Elizabeth Warren, @SenWarrenJoe Kernen, @JoeSquawkBecky Quick,@BeckyQuickKatie Kramer,@Kramer_Katie

Needham is upgrading Disney to buy for the first time in five years. The analyst behind that call joins us with what's behind the decision. Plus, the S&P is nearing a record but our guest is bargain hunting in the beaten-down parts of the market and brings us his favorite names. And Philip Morris' fastest-growing, tobacco-free product is facing some criticism from Capitol Hill. We'll speak to an analyst about what it means for the stock, and former FDA Commissioner Dr. Scott Gottlieb for the impact on consumers.

–Monday December 4th 2023—   —Here are 3 big things you need to know—   One — The Iranian-backed Houthis are claiming responsibility for attacks on three commercial ships in the Red Sea Sunday.  The USS Carney shot down several drones that officials say were launched from Houthi-controlled parts of Yemen, just a month after it shot down rockets and drones fired by Houthi militants.  U.S. Central Command said that the attacks represent a direct threat to international commerce and maritime security.     Two—  The strike at the MGM Grand Detroit Casino is over after 47-days.  The union has ratified the contract with the casino after they voted down a tentative deal last month.  The Detroit Casino Council says it includes an immediate 18-percent pay raise on average and has the largest-ever wage increases.      And number three — A leading national health expert says the U.S. should experience a more typical flu and virus season this winter.  Speaking on CBS' Face the Nation, former FDA Commissioner Dr. Scott Gottlieb says the level of RSV and flu cases is abating, compared to epidemic numbers in past years.  He added the number of COVID cases are down from past years.  

Fed Chair Jerome Powell says he and his fellow policymakers are encouraged by the slowing pace of inflation, but are unsure whether they've done enough to keep the momentum going. We'll explore.Plus, could Eli Lilly's new weight loss injectable become the best-selling drug on the market? That's what one analyst already said. We'll discuss with former FDA Commissioner Dr. Scott Gottlieb.

Consumer confidence is down but our market guest is staying positive on the markets and has one group of stocks she says is poised to benefit. Plus, the list of the first 10 drugs targeted for Medicare negotiations is out, and former FDA Commissioner Dr. Scott Gottlieb is warning of unintended consequences. And on the heels of the latest Case-Shiller housing report, Yale Professor Robert Shiller joins us to discuss the findings and where housing prices could go from here. 

This week on Face the Nation, yet another extraordinary severe weather event with a West Coast Hurricane, and Republican presidential candidates prepare for the first debate -- without Donald Trump. As the recovery efforts continue in Maui, the questions about the state and local response continue to grow, we spoke exclusively with Hawaii's governor Joshua Green. Plus, with coronavirus cases on the rise, former FDA Commissioner Dr. Scott Gottlieb will tell us what we need to know about the new arsenal of fall vaccines to fight covid, the flu, and RSV.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Target slashed its sales and profit expectations in its latest quarterly report. CNBC's Courtney Reagan and Forrester Research's Sucharita Kodali explain the retailer's troubles, from inflation-conscious shoppers to Pride month backlash. A new strain of Covid-19 is hitting the American South and West; former FDA Commissioner Dr. Scott Gottlieb explains the risks, the relevance of vaccinations and boosters for immunity, and this phase of endemic Covid. Plus, there are new court filings in the federal case against FTX founder Sam Bankman-Fried, a new deal could breathe life into Wheels Up stock, X Corp. has rebranded Tweetdeck, and Cava is hoping to satisfy Wall Street's appetite.  Sucharita Kodali - 15:17Courtney Reagan - 11:44Dr. Scott Gottlieb - 24:09 In this episode:Sucharita Kodali, @smulpuruScott Gottlieb, MD, @ScottGottliebMDCourtney Reagan, @courtreaganMelissa Lee, @MelissaLeeCNBCJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

Frank Yiannas is a food safety culture expert, a food safety executive at global brands, an author, and an adjunct professor. He served as the Deputy Commissioner of Food Policy and Response at the U.S. Food and Drug Administration (FDA) from 2018–February 2023. While at FDA, he was instrumental in creating the New Era for Smarter Food Safety blueprint and many other initiatives related to the implementation of the Food Safety Modernization Act (FSMA). Frank has also held food safety leadership roles with Walmart and the Walt Disney Company. Additionally, he advanced global thinking on food safety culture with his pivotal 2008 book, Food Safety Culture: Creating a Behavior-Based Food Safety Management System. Frank has long been recognized for his role in elevating food safety standards and building food safety management systems based on science and risk. In this episode of Food Safety Matters, we speak with Frank [24:37] about: The differences and similarities between working in food safety in the public and private sectors, and how improved public-private communication is required to drive food safety advancements Surprises that Frank encountered in transitioning to FDA from the private sector, and how his industry experience prepared him for his role at FDA Frank's proudest accomplishments with FDA, including FSMA implementation and efforts under the New Era of Smarter Food Safety Three big lessons Frank learned about the U.S. food system and food safety regulation during his time at FDA Frank's advice to “not hesitate… go bold” regarding the “new vision” proposed for FDA's Human Foods Program by FDA Commissioner Dr. Robert Califf Why “advancing food safety is impossible without change,” and what types of changes at FDA would most benefit U.S. food safety What Frank is looking forward to achieving in the next chapter of his post-FDA career, and what he means when he says he wants to take care of #UnfinishedBusiness. News and Resources USDA-FSIS Summarizes Foodborne Illness Outbreak Investigations, Sampling Activities for 2022 [3:55] Most Major Food Allergen Recalls Caused by Preventable Labeling Errors, Study Finds [8:11] FAO, WHO Publish First Global Report on Cell-Based Food Safety [20:49] Frank Yiannas Smarter Solutions  Food Safety Magazine's "Evolution of New Era: Advancing Strategies for Smarter Food Safety" Webinar Series: FDA's Food Safety Culture—Advancing Culture Throughout the Supply Chain  FDA's Retail Modernization—Foodborne Illness Prevention at the Federal, Industry, State, and Local Levels  FDA's Tech-Enabled Traceability—New Standards to Improve Food System Transparency  FDA's Smarter Tools—How Remote Regulatory Assessments Help Ensure Food Safety Food Safety Summit 2023 Register for the 2023 Food Safety Summit with discount code FSM23Podcast for 10% off! Sponsored by:Trustwell We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com

Stocks finished mixed and near worst levels. Vital Knowledge's Adam Crisafulli and Cantor Fitzgerald's Eric Johnston battle out where the market goes from here in a bear versus bull debate. Evercore analyst CJ Muse on why it's a “stock-pickers paradise” in the chips sector. Tilray shares fell today. CEO Irwin Simon discusses the latest quarter and big acquisition. CrowdStrike hosted its first ever government summit. CEO George Kurtz joins from there to talk public/private partnerships in cloud and cybersecurity. Why Weight Watchers soared nearly 60% higher today and our Meg Tirrell discusses the weight loss drug market with the FDA Commissioner Dr. Califf. Plus, former Kansas City Fed President Thomas Hoenig on upcoming inflation data, short seller Brad Lamensdorf on CarMax and our Mackenzie Sigalos on bitcoin's recent rally.

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic. He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the 'leading cause of death in America now.' Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic.He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the 'leading cause of death in America now.' Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic. He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the 'leading cause of death in America now.'

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic. He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the ‘leading cause of death in America... Read More Read More The post FDA Commissioner Dr. Robert Califf Discusses the Top News Stories appeared first on Healthy Communities Online.

The Rich Zeoli Show- Full Episode (03/06/2023): 3:05pm- According to The New York Post's Miranda Devine, “[n]ew emails uncovered by House Republicans probing the COVID-19 pandemic reveal the deceptive nature of Dr. Anthony Fauci.” In early 2020, Fauci commissioned a paper to “disprove the theory that the virus leaked from a lab in Wuhan, China.” You can read the opinion editorial here: https://nypost.com/2023/03/05/new-emails-show-fauci-commissioned-paper-to-disprove-wuhan-lab-leak-theory/ 3:30pm- Appearing on Fox News with Maria Bartiromo, Congressman Jim Jordan (R-OH) addressed allegations that Dr. Anthony—as Director of the National Institute of Allergy and Infectious Disease—pushed researchers to disprove the laboratory leak theory. Rep. Jordan called for greater transparency immediately. 3:40pm- While speaking with Margaret Brennan, former FDA Commissioner Dr. Scott Gottlieb said, “I think we should work under the assumption that there is a probability [the COVID-19 pandemic] was a lab leak…we ought to look into outlawing that kind of research…or conduct it in… high security labs.” 3:50pm- Former Secretary of State Mike Pompeo told Fox News' Shannon Bream that he has no doubt that COVID-19 originated from a laboratory leak in Wuhan, China and accused Dr. Anthony Fauci of being “complicit” in its cover-up. 4:05pm- Speaking at the 2023 Conservative Political Action Coalition (CPAC) taking place outside of Washington, D.C., former President Donald Trump referred to the World Health Organization (WHO) as “We Hide Outbreaks.” Trump also told members of the press that China needs to be held accountable for the COVID-19 outbreak, accusing China of costing the world economy an estimated $50 trillion in economic growth. 4:10pm- On Sunday, Florida Governor Ron DeSantis spoke at the Ronald Reagan Presidential Library in Ventura, California. During his speech, in front of a packed crowd, Gov. DeSantis criticized California Governor Gavin Newsom, Disney, and woke ideology. 4:15pm- Former United States Ambassador to the United Nations Nikki Haley spoke at the 2023 Conservative Political Action Coalition (CPAC) taking place outside of Washington, D.C. over the weekend. Her speech was not well attended—is she just campaigning to be the eventual Republican Presidential nominee's Vice President? 4:35pm- According to The New York Post, the Minnesota Department of Human Rights has ordered USA Powerlifting to permit biological males who identify as female to compete in the women's division. 4:55pm- New York City Mayor Eric Adams is now telling citizens to remove their face masks when entering a store—in hopes of cracking down on shoplifting. 5:05pm- The Drive at 5: According to a report from Ari Blaff at National Review, “Southern Poverty Law Center (SPLC) staff attorney Thomas Jurgens was among the dozens of rioters arrested following a violent attack on police at the proposed site of the Atlanta Police Foundation's training facility, located a few miles south of the city.” The Southern Poverty Law Center is notorious for inaccurately labeling mundane conservative organizations as dangerous, hate groups. You can read the report at: https://www.nationalreview.com/news/dozens-arrested-for-attacking-cops-with-molotov-cocktails-bricks-at-atlanta-training-facility/?utm_source=email&utm_medium=breaking&utm_campaign=newstrack&utm_term=30748108 5:20pm- In response to Hershey's decision to go “woke”, The Daily Wire has released its own brand of chocolate and has already sold over 300,000 candy bars in the first 36-hours of their release. 5:35pm- According to reports, author R.L. Stine intends to edit his “Goosebump” books to have more inclusive language. 5:40pm- Comedian Chris Rock addressed Will Smith's 2022 Oscars slap during a live Netflix stand-up special on Saturday. 6:05pm- A New York Times opinion editorial by David Wallace-Wells theorizes that “we've been talking about the lab-leak hypothesis all wrong.” Wallace-Wells writes, “if you had been told, back in 2019, that this would be the state of knowledge in 2023, would it not seem extremely weird to you that there has not been a broad public conversation about the wisdom of potentially dangerous virological research in the meantime? That so much more oxygen had been eaten up by partisan theater than by public debate over the policy implications of such a possibility?... The boundaries of mainstream discourse have suggested that we should resolve the matter of pandemic origins before moving on to the implications of the lab-leak hypothesis. But this has proved a paralyzing standard.” You can read the editorial here: https://www.nytimes.com/2023/02/28/opinion/lab-leak-energy-department-covid.html 6:30pm- A New York Times opinion-columnist says he can no longer enjoy McDonald's because his socio-economic status has changed after attending Yale—and, consequently, fast food is now beneath him. 6:45pm- Russell Brand accuses MSNBC of bias while on HBO's Real Time with Bill Maher. FLASHBACK: MSNBC's greatest lies!

The Rich Zeoli Show- Hour 1: According to The New York Post's Miranda Devine, “[n]ew emails uncovered by House Republicans probing the COVID-19 pandemic reveal the deceptive nature of Dr. Anthony Fauci.” In early 2020, Fauci commissioned a paper to “disprove the theory that the virus leaked from a lab in Wuhan, China.” You can read the opinion editorial here: https://nypost.com/2023/03/05/new-emails-show-fauci-commissioned-paper-to-disprove-wuhan-lab-leak-theory/ Appearing on Fox News with Maria Bartiromo, Congressman Jim Jordan (R-OH) addressed allegations that Dr. Anthony—as Director of the National Institute of Allergy and Infectious Disease—pushed researchers to disprove the laboratory leak theory. Rep. Jordan called for greater transparency immediately. While speaking with Margaret Brennan, former FDA Commissioner Dr. Scott Gottlieb said, “I think we should work under the assumption that there is a probability [the COVID-19 pandemic] was a lab leak…we ought to look into outlawing that kind of research…or conduct it in… high security labs.” Former Secretary of State Mike Pompeo told Fox News' Shannon Bream that he has no doubt that COVID-19 originated from a laboratory leak in Wuhan, China and accused Dr. Anthony Fauci of being “complicit” in its cover-up.

Dean Lloyd Minor welcomes former FDA commissioner Dr. Scott Gottlieb to discuss the role of government agencies in improving public health and handling crises. During their conversation, they examine the influence of business, politics, and finance on science and medicine, how to strike a balance between innovation and regulation in the health market, and changes that would better prepare the U.S. for the next public health crisis.  They also dive into the importance of active listening in leadership, being open to new organizational mindsets, and anticipating the range of reactions from businesses, communities, and individuals in times of uncertainty.

Throughout COVID-19, the FDA has been among many government agencies charged with communicating lifesaving information. Commissioner Dr. Robert Califf talks with Dr. Josh Sharfstein about how the politicization of the pandemic raised the stakes for the FDA and how the agency is learning to adapt in an age of rampant misinformation. They also discuss the FDA's consideration of bivalent vaccines for authorization and what's next for the pandemic response. 

Editor's Commentary: What's the rush? Alleged deaths from Covid-19 are way down. Omicron has proven to be a nothingburger that is akin to a mild flu or average cold. So why are they pushing to get new Omicron-specific jabs rolled out before knowing anything about them?The answer to the question is pretty obvious if you've been paying attention the last couple of years. They need to get as many men, women, and children jabbed as many times as possible in as short of a time as possible because the truth is finally starting to be embraced by "normies." People are waking up to the reality that these injections are neither safe nor effective, so the powers-that-be have accelerated their plans for the new boosters.I talked about this today on the latest episode of The JD Rucker Show. Here's the relevant clip, followed by the article referenced in it by Mac Slavo at SHTF Plan.The new COVID-19 booster shots said to target Omicron, will be released before the human trials are completed. What could possibly go wrong?The Food and Drug Administration will be approving the new boosters sometime this week before the human testing can be finished. That means, all the data they have to "approve" these injections is incomplete, and delayed side effects or deaths won't be considered as a part of the FDA's "approval" process. Not that they were when the first COVID shots were released either, so this really isn't that surprising.According to a new report by the Wall Street Journal, the new boosters are similar to the COVID vaccines currently available in the United States with minor modifications that protect recipients from the latest version of the Omicron variant. That's good news, considering people are now dying of SADS (sudden adult death syndrome) and getting AIDS from taking the first few injections.Sudden Vaccines Deaths So Common They Have A Name: Sudden Adult Death Syndrome (SADS)U.S. Ruling Class Data: Fully "Vaccinated" Are Developing AIDSInstead of waiting on data from testing these injections on humans, the agency will use data from trials in mice (which are not at all similar to humans in any way) as well as the "real-world" evidence of the safety of currently available COVID vaccines and test results from earlier iterations of boosters targeting older strains to evaluate the newest boosters, FDA Commissioner Dr. Robert Califf said.Evidence like this: COVID-19 Jabs Have "Real-World" Immunity of MINUS 73%, Meaning People Are LOSING IMMUNITY"Real-world evidence from the current mRNA COVID-19 vaccines, which have been administered to millions of individuals, show us that the vaccines are safe," Califf said on Twitter. "As we know from prior experience, strain changes can be made without affecting safety."COVID Vaccine Deaths Reported to CDC Equal to ALL Vaccine Death Reports Over Last 20 YearsHe added that modifying existing vaccines to include protection against different viral strains doesn't require a change in ingredient and is a common practice the FDA does with flu vaccines. "FDA has extensive experience with reviewing strain changes in vaccines, as is done with the annual flu vaccine," Califf said.The United Kingdom is already being subjected to these new "vaccine" boosters too. We had mentioned it wouldn't take the U.S. long to follow suit:UK Authorizes Another Booster Vaccine For "Variants"At least two scientists have stepped up saying it's a bad idea to push these vaccines on the public based on mouse data. The experts penned an op-ed demanding that the FDA not rush through the roll-out of the newest shots. "I'm uncomfortable that we would move forward — that we would give millions or tens of millions of doses to people — based on mouse data," one of the authors, Paul Offit, told the Journal.Offit, an FDA adviser and director of the Vaccine Education Center at Children's Hospital of Philadelphia, believes the comparison between flu shots and COVID-19 shots is not well grounded due to the differences in mutations and protection levels.But it's unlikely to matter at all. Because if the ruling class wants shots that amount to genocide, that's what they will get. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit endmedicaltyranny.substack.com

This week on "Face the Nation with Margaret Brennan," we talk to Florida Republican Sen. Rick Scott about the party's opposition to the Democrats' economic plan, and former FDA Commissioner Dr. Scott Gottlieb returns to discuss the monkeypox health emergency. And after a surprising July jobs report, we talk to San Francisco Federal Reserve Bank President and CEO Mary Daly about what it means for the U.S. economy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

President Biden is set to sign the Chips and Science Act, aimed to support US semiconductor manufacturing. Senator Maria Cantwell (D-WA) discusses the bipartisan effort to boost US competitiveness with China and other major chips producers. Also in Washington, Senator Kyrsten Sinema (D-AZ) has finally signed off on the Inflation Reduction Act, the Democrats' reconciliation bill that includes hundreds of billions of dollars in spending on climate, health care initiatives. CNBC's Ylan Mui reports that her support could cement the votes needed to pass the bill; the “vote-a-rama” starts this Saturday, so the Senate will be working through the weekend. The Biden administration has declared monkeypox a national health emergency, and former FDA Commissioner Dr. Scott Gottlieb answers questions about its spread, its virulence, and the health system's path forward. Plus, Visa CEO Al Kelly has issued a statement on the MindGeek child pornography lawsuit, and Warner Bros. Discovery hosted its first earnings call since its merger.  In this episode:Sen. Maria Cantwell, @SenatorCantwellYlan Mui, @ylanmuiJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @AndrewrsorkinKatie Kramer, @Kramer_Katie

Elon Musk is over Twitter. He's aiming to terminate the $44 billion dollar deal, and Twitter's ready to take him to court over it, but Musk is seemingly unbothered by the drama. Former SEC Chair Jay Clayton maps out the various outcomes at this stage in Twitter-Musk saga. Covid cases are ticking up as we head into the end of the summer, and while most of us have readjusted our individual risk calculus to allow for normal life, former FDA Commissioner Dr. Scott Gottlieb suggests keeping our masks on. Leaked documents from Uber's past are raising questions about the company's ethical foundation, and Starbucks is rolling back a new, potentially questionable offering. Plus, President Biden is gearing up for his first in-office trip to Saudi Arabia. In this episode:Dr. Scott Gottlieb,@ScottGottliebMDJoe Kernen,@JoeSquawkAndrew Ross Sorkin,@AndrewrsorkinCameron Costa,@CameronCostaNY

The unknown health effects of e-cigarettes and vaping products have long been discussed but recently the Food and Drug Administration has announced plans to remove all products from the popular e-cigarette company Juul from shelves due to insufficient public health data. This past week, the FDA dropped their suspension of Juul and the Juul company agreed to suspend their court case while the government reopens its investigation into the company's products. Earlier this week, former FDA Commissioner Dr. Scott Gottlieb joined the podcast to break down the thought process behind the FDA's initial decision, the effect this could have on smokers attempting to quit, and how this could deter youth from vaping. Due to time limitations, we could not include all of the interview in our original segment. Today on the FOX News Rundown Extra, you will hear our entire interview with Dr. Gottlieb about this decision and how it could impact the vaping and tobacco industry. Learn more about your ad choices. Visit megaphone.fm/adchoices

The unknown health effects of e-cigarettes and vaping products have long been discussed but recently the Food and Drug Administration has announced plans to remove all products from the popular e-cigarette company Juul from shelves due to insufficient public health data. This past week, the FDA dropped their suspension of Juul and the Juul company agreed to suspend their court case while the government reopens its investigation into the company's products. Earlier this week, former FDA Commissioner Dr. Scott Gottlieb joined the podcast to break down the thought process behind the FDA's initial decision, the effect this could have on smokers attempting to quit, and how this could deter youth from vaping. Due to time limitations, we could not include all of the interview in our original segment. Today on the FOX News Rundown Extra, you will hear our entire interview with Dr. Gottlieb about this decision and how it could impact the vaping and tobacco industry. Learn more about your ad choices. Visit megaphone.fm/adchoices

The unknown health effects of e-cigarettes and vaping products have long been discussed but recently the Food and Drug Administration has announced plans to remove all products from the popular e-cigarette company Juul from shelves due to insufficient public health data. This past week, the FDA dropped their suspension of Juul and the Juul company agreed to suspend their court case while the government reopens its investigation into the company's products. Earlier this week, former FDA Commissioner Dr. Scott Gottlieb joined the podcast to break down the thought process behind the FDA's initial decision, the effect this could have on smokers attempting to quit, and how this could deter youth from vaping. Due to time limitations, we could not include all of the interview in our original segment. Today on the FOX News Rundown Extra, you will hear our entire interview with Dr. Gottlieb about this decision and how it could impact the vaping and tobacco industry. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today we take a look at an article highlighting some of the FDA Commissioner Dr. Robert Califf's testimony to congress on CBD and kratom last month. (*Sources in this episode can be found below.) * https://www.painnewsnetwork.org/stories/2022/5/20/fda-head-new-regulations-needed-for-kratom-and-cbd Please support this podcast here! https://www.paypal.me/everythingkratom Or make a small monthly donation here! https://anchor.fm/everything-kratom/support Get 25% off orders from ETHA Natural Botanicals with coupon code EVERYTHINGKRATOM, or visit their website using this link - https://ethalivefully.com/discount/EVERYTHINGKRATOM?aff=243 Available wherever you get your podcasts: Anchor - https://anchor.fm/everything-kratom Spotify - https://open.spotify.com/show/2fO3Xsx1BbNUs2rpXiQs3s Google Podcasts - https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy82OWUxMzZjNC9wb2RjYXN0L3Jzcw== Apple Podcasts - https://podcasts.apple.com/us/podcast/everything-kratom/id1584592399 Pocket Casts - https://pca.st/mql8q14u RadioPublic - https://radiopublic.com/everything-kratom-WzkkBK Overcast - https://overcast.fm/itunes1584592399/everything-kratom Reason - https://reason.fm/podcast/everything-kratom?user=16e32b81-d623-4dcd-a000-623566fdc41a YouTube Channel: https://www.youtube.com/channel/UCUsCC1nBchi_xMX9wRyQ_nA Website: https://everythingkratom279311648.wordpress.com Thank you all so much for listening! --- Send in a voice message: https://anchor.fm/everything-kratom/message Support this podcast: https://anchor.fm/everything-kratom/support

This week on “Face the Nation with Margaret Brennan,” we discuss the Jan. 6 hearings with Rep. Zoe Lofgren, a Democrat from California, go over the recently approved COVID-19 vaccine for kids with former FDA Commissioner Dr. Scott Gottlieb and take a look at America's inflation problem.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's episode, I can't believe I have to open with an explanation of inanimate objects. To illustrate, I took my handgun out recently, put it on the table and yelled at it. I called it names, I mocked it, belittled it, made it feel inferior and unloved. No matter what I tried, I could not get the gun to shoot. It seemed content to sit there and do nothing. That's the point. A car is no more a living being than a gun. Cars don't choose to start up and drive down the road looking for a gathering of parade-goers to run over. To pretend the only solution is to blame the inanimate object shows the Left is not really interested in solutions. They only want talking points and campaign promises when it comes to guns. First off, President Joe Biden once again repeated the fallacy (fact-checked numerous times) that the 2nd Amendment prevented Americans from owning canons. The is but factually and legally false. There was nothing at all in the Constitution preventing canon ownership. In fact, there is a section in the Constitution giving privateers legal authority to arm their ships and go after bad guys on the high seas. So, when the president is clueless about the 2nd Amendment, why should we be surprised to find so many on the Left are equally clueless. Until we make a point of solving the cultural issues that lead the creation of mass-shooters, we have to look for better solutions. Going door-to-door in search of confiscating 400M guns is just not feasible and will never happen. Instead, simple solutions like limiting points of entry, on-site security, staff training and drills are ways to mitigate the risks from an active shooter. As we learn more about the specific incident in Texas, we are now finding out local police did not enter the school. They stopped parents from entering who were shouting at them to do something. They were obviously too afraid or lacked the training to deal with an active shooter scenario. Reports show the shooter was inside from 40 minutes to an hour before the special border patrol team arrived and eventually entered, taking out the heinous murderer. That is unacceptable! Shifting for a moment, even CNN is now reporting on the poor management by the FDA as it relates to the infant formula crisis. I include a short time line from CNN's Elizabeth Cohen as FDA Commissioner Dr. Robert M. Califf is set to face another grilling from the Senate. As I close out, I shift over to some health news as it relates to respiratory infections. Dr. Robert Malone recently discussed more studies continuing to show individuals with 50ng/liter levels of vitamin D had no mortality when it came to the recent pandemic. It reinforces what I've been trying to tell my audience for over 18 months and continue to preach over and over, even though I have been flagged for spreading “disinformation” about it. And, to cap it off, there are now well over 150 of the highest-quality, complete and robust studies showing beyond the shadow of a doubt, natural immunity acquired through infection is the best, strongest and most long-lasting protection you can have for the recent virus that was used to shut down so much of the Western world. The fact so many leaders in public health intentionally lied about that for so long should be considered a criminal act. Take a moment to rate and review the show and then share the episode on social media. You can find me on Facebook, Twitter, Instagram, GETTR and TRUTH Social by searching for The Alan Sanders Show.

Commissioner of Food and Drugs at the FDA Dr. Robert M. Califf joins Dr. Marc Siegel and discusses the changing narrative on Covid19 vaccines and their importance, the role of Paxlovid in treating Covid19, the overdose epidemic, and why he believes misinformation is the leading cause of death.

This week on “Face the Nation with Margaret Brennan,” we'll have the latest on U.S. Secretary of State Antony Blinken and Defense Secretary Lloyd Austin's visit to war-torn Ukraine and a Sunday exclusive interview with Ukrainian Prime Minister Denys Shmyhal. Plus, we check in with former FDA Commissioner Dr. Scott Gottlieb on the long-awaited COVID vaccine for America's youngest. Also joining the program is European Central Bank President Christine Lagarde, to discuss the impact of the war in Ukraine on inflation and the economy globally.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The bond market briefly flashed a warning that recession could be imminent; Joe Kernen, Becky Quick, Andrew Ross Sorkin, and CNBC's senior economics reporter Steve Liesman explain Wall Street's hype about the inverted yield curve. The other talk on Wall Street: a social breakfast between Activision Blizzard CEO Bobby Kotick and trader Alexander von Furstenberg that's now in the center of official probes into insider trading concerns. Also caught up in the probes are billionaire magnates Barry Diller and David Geffen. Plus, China is in the thick of another battle with Covid, but here at home, former FDA Commissioner Dr. Scott Gottlieb says, we're nearing the end of its pandemic phase.   In this episode:Dr. Scott Gottlieb, @ScottGottliebMDSteve Liesman, @steveliesmanBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkKatie Kramer, @Kramer_Katie

This week on “Face the Nation” with no end in sight for the war in Ukraine moderator Margaret Brennan has exclusive interviews with Secretary of Defense Lloyd Austin on the new weapons being sent to Ukraine and the diplomatic approach to arming them. Chinese Ambassador to the U.S. Qin Gang on the relations between the U.S. and China after President Biden warns Beijing not to help Russia with its invasion. Ukrainian Ambassador to the U.S. Oksana Markarova on her country's battle against Russia. A rare Sunday interview with Senate Minority Leader Mitch McConnell. And former FDA Commissioner Dr. Scott Gottlieb on the latest Covid news. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Senate confirmation of FDA Commissioner Dr. Robert Califf (00:34), the first female to be cured of HIV (04:47), a recent report on hospital price transparency (07:28), and an acquisition announcement from ChristianaCare (13:18). Podcast Tags: healthcare, healthcare news, FDA, public health, stem cells, price transparency, healthcare costs, hospitals, acquisitionsSource Links: · https://www.reuters.com/world/us/us-senate-confirms-bidens-fda-nominee-califf-2022-02-15/· https://www.nytimes.com/2022/02/15/health/hiv-cure-cord-blood.html?· https://www.bloomberg.com/news/articles/2022-02-09/trump-era-rule-to-report-hospital-pricing-gets-off-to-slow-start?mkt_tok=ODUwLVRBQS01MTEAAAGCgsedUi88cCl4sxBtLK4zJvQHyVx22C4bikTEBm0463vfILf5EcMA-H7r45HnBEmv3ohUnoZU5AEBnCWqhaU_gIHL14Tv-e8f5By7eezCyHB5 · https://www.fiercehealthcare.com/hospitals/report-143-hospitals-compliant-price-transparency-rules-one-year?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=3569J2000334E1H · https://www.fiercehealthcare.com/hospitals/christianacare-looking-acquire-crozer-health-prospect-medical-holdings?utm_source=email&utm_medium=email&utm_campaign=HC-NL-FierceHealthcare&oly_enc_id=3569J2000334E1H For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. Mindy McGrath, Healthcare Industry Advisor mindy.mcgrath@vynamic.comRyan Hummel, Executive and Head of Provider Sectorryan.hummel@vynamic.comJen Burke, Healthcare Industry Strategistjen.burke@vynamic.com

Now that the US Senate has confirmed Dr. Robert Califf as Commissioner of the US Food and Drug Administration, a position he held briefly in the Obama Administration, we turn to the priorities and perspective he is likely to bring to the agency. Making big data, including from electronic health records, useful for research and sufficient to support FDA regulatory decision-making emerged as a major theme from Califf's Senate testimony. How might he employ big data to achieve his stated goals of improving emergency preparedness and response, modernizing the FDA, and ensuring the safety of FDA-regulated products already on the market? In this episode of Connected With Latham, New York partner Nathan Ajiashvili discusses this question and more with Washington, D.C.-based Healthcare & Life Sciences partners John Manthei, Global Chair of the practice, and Ben Haas, as well as associate Nathan Beaton.    This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York's Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York's Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200

On this week's "Face the Nation" with moderator Margaret Brennan, Inflation worries, lifted mask mandates, and updates on the Russia-Ukraine crisis and the January 6th insurrection. We'll hear from National Security Advisor, Jake Sullivan, CBS's David Martin, Federal Reserve President Mary Daly, New Jersey Governor Phil Murphy. Rep. Kinzinger (R-IL.) We'll get our weekly covid update from former FDA Commissioner Dr. Scott Gottlieb. Plus, a new CBS News poll on the mental health of children as education continues during the pandemic. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's "Face the Nation" with moderator Margaret Brennan, Ukrainian President Zelensky is asking the U.S. to tone down the rhetoric around a possible Russian invasion of his country. She discusses how her country is viewing Russia's military build-up on their border. is asking the U.S. to tone down the rhetoric around a possible Russian invasion of his country. One of President Biden's top diplomats, Victoria Nuland, joins discusses efforts to find a peaceful solution to the Ukraine-Russia Crisis. House Majority Whip James Clybburn (D-SC) says he urged President Biden to nominate a black woman to the Supreme Court back in 2020. Following the retirement of Justice Stephen Breyer, he believes South Carolina judge Michelle Childs should be the one. Senator Lindsay Graham (R-SC) discusses President Biden's pending Supreme Court nomination and the latest in the ongoing Ukraine-Russia crisis. Finally, former FDA Commissioner Dr. Scott Gottlieb has the latest on the coronavirus -- including new variants, guidelines, and more. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's "60 Minutes" with moderator Margaret Brennan: The COVID pandemic, inflation, voting rights, and more! We asked Americans how they feel the Biden administration is handling the issues impacting them the most. Plus, CBS News Election and Surveys Director Anthony Salvanto with a poll on President Biden's first year in office. An statement that the Omicron variant will most likely infect everyone and the CDC's update to mask guidance this week has confused many Americans on how to best protect themselves from COVID. We'll hear from former FDA Commissioner Dr. Scott Gottlieb. Medical experts believe the Omicron wave is headed for the Midwest next. Kansas City Mayor Quinton Lucas discusses how he plans to protect his citizens from the coronavirus.Democrats' renewed push for voting rights legislation may be tied to filibuster reform. We talk to Senator Tim Kaine (D-VA) for perspective on how the party can get movement on this issue, Build Back Better, and their other priorities in 2022.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's "Face the Nation," moderator Margaret Brennan's exclusive interview with House Speaker Nancy Pelosi, who talks about what to expect from Democrats in 2022. We'll hear from David Becker, the Executive Director and Founder of the Center for Election Innovation Research, about the state of elections and American's confidence stands. Georgia Secretary of State Brad Raffensperger defends his state's 2020 election integrity to former President Trump, and talks about the future of elections in Georgia after the state legislation stripped his position of oversight. Newly appointed New York City Mayor Eric Adams, discusses what he plans to do about the surging COVID19 cases. As COVID cases continuing to rise, we turn to former FDA Commissioner Dr. Scott Gottlieb for his expertise on how to best protect yourself. Meanwhile, President Putin is essentially playing a game of chicken, a Cold War style game of brinkmanship that is ratcheting up tensions, trying to extract concessions from the US and its European allies, We'll get the latest from CBS's Holly Williams.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Global markets are wavering as cases of the omicron variant ticks up around the world. Moderna says its Covid booster dose does bolster antibodies against the new variant, but even so, CNBC's Robert Frank reports that big banks are reversing their return-to-work policies. CNBC's Meg Tirrell explains the Moderna news and compares data on cases of Covid's omicron and delta variants, and former FDA Commissioner Dr. Scott Gottlieb offers best testing practices to families hoping to gather for a safe holiday. In light of the latest surge, the World Economic Forum usually held in January in Davos has been postponed. Plus, CNBC's Eamon Javers discusses Senator Joe Manchin's (D-WV) decision not to support President Biden's Build Back Better plan, a blow for Democrats and the administration.  In this episode:Dr. Scott Gottlieb, @ScottGottliebMDRobert Frank, @robtfrankMeg Tirrell, @megtirrellJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

On this week's "Face the Nation" with moderator Margaret Brennan, America's new COVID crisis: Omicron and Delta cases spread across the country as millions prepare to gather for the holidays. We'll hear from former FDA Commissioner Dr. Scott Gottlieb and NIH Director, Dr. Francis Collins. We're joined by DEA Administrator Anne Milgram, who discusses the opioid crisis being fueled by fentanyl. Plus, a discussion with Afghanistan's former National Security Adviser Hamdullah Mohib for his first English-language broadcast interview since Afghanistan fell to the Taliban in August.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

CBS News has confirmed at least 25 deaths in the aftermath of Friday's trail of tornadoes that barreled through six states -- Arkansas, Missouri, Mississippi, Tennessee, Illinois and Kentucky. CBS's David Begnaud reports. CBS meteorologist and climate specialist Jeff Berardelli breaks down how climate change could have been a major factor in the deadly tornadoes. We'' hear from Kentucky Governor Andy Beshear, Arkansas Governor Asa Hutchinson, U.S. COVID-19 cases are up 37-percent from last week, and the Omicron variant has been found in 27 states. CBS's Mark Strassmann reports on the ongoing impacts of the coronavirus pandemic in the United States. Are the un-vaccinated driving the spread of infections in the U.S. and should states reinstate mask mandates? We'll hear from former FDA Commissioner Dr. Scott Gottlieb. COVID-19 cases have spiked 25-percent in New Hampshire over the last two weeks. Governor Chris Sununu attributes this to colder months, but says his state has been preparing for the surge since July. Tulio de Oliveira, Director of CERI: Centre for Epidemic Response & innovation, South Africa. An analysis of these stories and more on this week's "Face the Nation" with Margaret Brennan.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's "Face the Nation" with moderator Margaret Brennan; five states have reported cases of the new Covid-19 Omicron Variant. Is it too early to sat if it has less severity as other variants? We'll hear from former FDA Commissioner Dr. Scott Gottlieb and Surgeon General Dr. Vivek Murthy. Just how widespread is the Omicron variant around the world, and how can surveillance and sequencing tell us? We get insight on the virus and its mutations with illumina Why is the new variant of concern for the global community? How can international partners better sequence further cases and strains? We get the latest with the WHO's COVID lead Dr. Maria Van Kerkhove. Is Connecticut, one of the states to report a case of the Omicron variant, prepared for potential winter surges of COVID-19 in the Northeast? How can the state work to keep schools open? We'll hear from Governor Ned Lamont. (D-CT) Plus, new travel rules -- what you need to know.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The markets are reacting to comments from Fed Chair Jerome Powell, who announced a plan to taper its asset purchases faster. He--and the rest of the economist community--is ready to retire the word “transitory,” but his comments have not retired questions and concerns from investors. CNBC's Steve Liesman explains Powell's comments. CEO of Lazard's Financial Advisory business Peter Orszag discusses Fed leadership and Lazard's efforts to quantify climate issues in the equities market. The FDA has narrowly endorsed Merck's oral Covid treatment pill; former FDA Commissioner Dr. Scott Gottlieb discusses therapeutics, vaccine efficacy against the omicron variant, and Covid-19's evolution. Plus, how much do you love Tesla? Enough for a tattoo? In this episode:Dr. Scott Gottlieb, @ScottGottliebMDPeter Orszag, @porszagSteve Liesman, @SteveLiesmanJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

On this week's "Face the Nation," moderator Margaret Brennan's wide-ranging interview Dr. Anthony Fauci, who warns of the potential for a fifth wave of COVID-19, stressing the need for boosters and vaccines. We'll get the latest on COVID-19 including what the new omicron variant means for Americans from former FDA Commissioner Dr. Scott Gottlieb. Plus, how will supply chain issues impact the holiday shopping season? We'll hear from Amazon's CEO, Dave Clark. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Pfizer's antiviral pill is 89% effective in cutting rates of hospitalization and death in Covid-19 patients. The news is huge for Pfizer and even bigger for the pandemic's trajectory in this country. CNBC's Meg Tirrell unveils the news, and Pfizer board member and former FDA Commissioner Dr. Scott Gottlieb says it means we are nearing “the end of the pandemic phase of this virus.” Plus, ‘The Sopranos' actor Steven Schirripa--the man behind Bobby ‘Bacala' Baccalieri--shares show secrets and behind the scenes history, and he extends the Sopranos family name to the Squawk team. Peloton shares are on the descent, and U.S. workers are headed out of their office doors.In this episode:Sharon Epperson, @Sharon_EppersonMeg Tirrell, @megtirrellDr. Scott Gottlieb, @ScottGottliebMDSteven Schirripa, @StevenSchirripaJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY 

Tuesday, October 26, 2021 - The North Dakota Human Rights Film Festival is coming up, with events being held around the state. It's a project of “The Human Family,” a North Dakota non-profit that seeks to make positive changes through art. Joining us to share some festival highlights are Sean Coffman, executive director of The Human Family; and Falcon Gott, the festival's Native American programming director. ~~~ In an excerpt from the Conversations on Healthcare podcast, we hear from former FDA Commissioner Dr. Scott Gottlieb. He discusses his new book, “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.”

This week, hosts Mark Masselli and Margaret Flinter speak with former FDA Commissioner Dr. Scott Gottlieb whose new book outlines America's epic failure in our response to the pandemic, leading to more than 700,000 deaths. “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic” examines the inherent flaws at the Centers for Disease Control and Prevention and other public agencies that left us vulnerable to the raging pandemic. Dr. Gottlieb says the CDC and other agencies should be re-tooled to conduct more agile global disease surveillance, and that emerging therapeutics like Merck's new oral COVID drug will be a game changer for treatment moving forward.

Jim Cramer and David Faber led off the show with a look at what investors should do in wake of the recent rally in energy prices: WTI crude surging to a seven-year high and natural gas up 50% over the past three months. The anchors highlighted Goldman Sachs lowering its U.S. growth forecasts for 2021 and 2022 as the firm expects a "delayed recovery in consumer spending" and no improvement in the global chip supply until next year. Jim and David also discussed a rough start for Southwest: Shares under pressure after the airline announced hundreds of additional flight cancellations on top of the 1,800 that took place over the weekend, citing bad weather, air traffic control issues and staff shortages. Southwest also disputes speculation that its high level of cancellations compared to other airlines were due to employee protests of a COVID-19 vaccine mandate. Speaking of the pandemic, Merck and Ridgeback Biotherapeutics announced submission of an emergency use authorization application to the FDA for their oral COVID-19 treatment. The anchors reacted to what former FDA Commissioner Dr. Scott Gottlieb told CNBC about when he believes Merck's COVID pill will hit the markets. Changes at the top of KKR: Co-founders Henry Kravis and George Roberts stepped down as Co-CEOs of the private equity firm. The anchors explored what this means for KKR and the world of P.E. Also in focus: Big banks kicking off earnings season later this week, Chinese stocks continue to rebound, Emerson Electric's $11-billion merger deal with Aspen Technology, and as movie theaters look to rebound from the pandemic -- the new James Bond film "No Time To Die" debuts by grossing $56-million at the box office domestically. It was the weekend's top performer but just shy of consensus estimates.

This week, hosts Mark Masselli and Margaret Flinter speak with former FDA Commissioner Dr. Scott Gottlieb whose new book outlines America's epic failure in our response to the pandemic, leading to more than 700,000 deaths. “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic” examines the inherent flaws at the Centers for Disease Control and Prevention and other public agencies that left us vulnerable to the raging pandemic. Dr. Gottlieb says the CDC and other... Read More Read More The post Why COVID Crushed Us: Former FDA Commissioner Dr. Scott Gottlieb Details America's Botched Pandemic Response appeared first on Healthy Communities Online.

On this week's "Face the Nation with moderator Margaret Brennan," confusion builds over who is eligible for COVID-19 vaccine boosters and when can they receive them. We'll hear from CDC Director Dr. Rochelle Walensky and former FDA Commissioner Dr. Scott Gottlieb. South Carolina Republican Senator Tim Scott discusses police reform and the migrant crisis on the Southern border and Washington Democratic Congresswoman Pramila Jayapal discusses infrastructure negotiations. Plus, interviews with Australian Prime Minister Scott Morrison about COVID-19, China and his country's new security contract with the U.S and U.K. Finally, we sit down with Turkish President Recep Tayyip Erdoğan to discuss press freedom in Turkey and the US exit from Afghanistan. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, Pfizer announced that a lower dose for its COVID vaccine is safe and effective for children ages 5-11. The company says it will seek FDA approval. Earlier this week, host Jessica Rosenthal spoke with former FDA Commissioner Dr. Scott Gottlieb who weighed in on children under the age of 12 being eligible for the vaccine and the FDA's recent decision regarding booster shots. Dr. Gottlieb also talked about his new book "Uncontrolled Spread." The conversation was too long and we could not include everything from the original conversation with Dr. Gottlieb. On today's Fox News Rundown Extra you'll hear more about his new book, that includes criticism of the Centers for Disease Control and Prevention, and why he thinks they were not the right agency to fully rely on to handle this pandemic. He explains some of the mistake the CDC made throughout the pandemic including their failure to deploy a diagnostic test at scale in the beginning of the coronavirus crisis. He also explains how the CDC's 6-feet requirement guidance was the single most costly recommendation in the entire pandemic. Plus, he shares how we can avoid these mistakes in the future.

This week, Pfizer announced that a lower dose for its COVID vaccine is safe and effective for children ages 5-11. The company says it will seek FDA approval. Earlier this week, host Jessica Rosenthal spoke with former FDA Commissioner Dr. Scott Gottlieb who weighed in on children under the age of 12 being eligible for the vaccine and the FDA's recent decision regarding booster shots. Dr. Gottlieb also talked about his new book "Uncontrolled Spread." The conversation was too long and we could not include everything from the original conversation with Dr. Gottlieb. On today's Fox News Rundown Extra you'll hear more about his new book, that includes criticism of the Centers for Disease Control and Prevention, and why he thinks they were not the right agency to fully rely on to handle this pandemic. He explains some of the mistake the CDC made throughout the pandemic including their failure to deploy a diagnostic test at scale in the beginning of the coronavirus crisis. He also explains how the CDC's 6-feet requirement guidance was the single most costly recommendation in the entire pandemic. Plus, he shares how we can avoid these mistakes in the future.

Carl Quintanilla, Jim Cramer and David Faber cap a roller coaster week for the market with a look at the tug-of-war between economic data versus supply chain issues and what's at stake for stocks. Pfizer and Moderna pushing for COVID vaccine booster shots ahead of a key FDA advisory committee meeting. The anchors reacted to what former FDA Commissioner Dr. Scott Gottlieb told CNBC about the age factor when it comes to administering boosters. Lots of electric vehicle news: Lucid shares extended sharp gains from Thursday, after the Environmental Protection Agency gave one of the startup's luxury sedans a record mileage rating of 520 miles. Tesla CEO Elon Musk complimented Chinese automakers in pre-recorded remarks to a green-vehicle conference in China, while Ford says it is ramping up production of its all-electric F-150 Lightning pickup truck. The anchors also discussed President Biden making the case for hiking taxes on corporations and the wealthy to pay for a $3.5-trillion reconciliation package while facing opposition from Sen. Joe Manchin (D-WV) who thinks the price tag is too high. Carl, Jim and David reacted to Mark Cuban's tweet that cryptocurrency "regulation built around existing fraud laws is not a bad thing" -- and looked back at what SEC Chair Gary Gensler told them, about crypto during Wednesday's interview. Also in focus: This week's strong Wall Street debuts from the likes of drive-through coffee chain Dutch Bros. and Swiss sneaker company On Holding, a closer look at the size of SPAC redemption, proxy advisor Institutional Shareholder Services recommends a "no" vote on Zoom Video's deal to acquire Five9, and tech CEOs Tim Cook, Elon Musk and Jensen Huang are added to the 2021 "Time 100" list.

In an extended interview, founder of Bridgewater Associates Ray Dalio outlines his strategy for diversifying his portfolio, from the stock market to gold and cryptocurrencies. Dalio discusses the global and domestic market risks, warns investors away from cash, and considers a conflicted future for capitalism. At the Skybridge Alternatives Conference in New York, Andrew Ross Sorkin sits down with Ray Dalio and, later, former FDA Commissioner Dr. Scott Gottlieb. Dr. Gottlieb considers a future of low-Covid-risk conferences like SALT, and a timeline for child vaccines. Plus, Microsoft is buying back $60 billion in MSFT stock

Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the markets this week in light of the big news of the morning: The FDA officially granting full approval to the Pfizer/BioNTech COVID-19 vaccine. The anchors discussed what this development could mean for the reopening trade, vaccine mandates and getting workers back into the office. Carl, Jim and David also reacted to former FDA Commissioner Dr. Scott Gottlieb's comments to CNBC about businesses mandating vaccine shots for workers. The Fed also in the spotlight ahead of Friday's Jackson Hole symposium, which is going virtual due to the Delta variant outbreak. The anchors explored whether Fed Chair Jerome Powell should hold off on his tapering strategy until we get more answers about how long Delta will impact the recovery. Also in focus: Bitcoin jumps back above $50,000 for the first time since May, a number of Wall Street firms initiating coverage of Robinhood nearly a month after its public debut, shares of Uber, Lyft and DoorDash take a hit after a California judge ruled the state's "gig worker" law to be unconstitutional, and Sir Richard Branson's Virgin Orbit satellite launch service planning to go public by combining with SPAC "NextGen Acquisition Corp. II" in a $3.2-billion deal.

After Target delivered second quarter financials topping all analyst expectations, CEO Brian Cornell sits down with Becky Quick to discuss his business investment strategies. The two talk omnichannel growth, employee support, and consumer tastes. The U.S. government is recommending vaccinated adults take a booster Covid-19 vaccine, and former FDA Commissioner Dr. Scott Gottlieb explains who, when, and why a booster is necessary for a safe public. Plus, Chinese tech giants are under scrutiny, and TikTok is back in the spotlight on Capitol Hill--this time, for its data.

Carl Quintanilla, Morgan Brennan and Mike Santoli led off the show with Disney, whose better-than-expected quarterly results drove the stock higher, leading the Dow and S&P 500 to new record intraday highs. The anchors reacted to what Disney CEO Bob Chapek's told CNBC about Disney+ adding subscribers despite a hike in the streaming service's rates. They also looked at how the company's theme parks are faring in light of rising COVID cases and the debate in Florida over requiring vaccinations and mask wearing. Sticking with the pandemic and the reopening trade, the Food and Drug Administration has authorized COVID vaccine booster shots for people with weakened immune systems. Carl, Morgan and Mike reacted to former FDA Commissioner Dr. Scott Gottlieb's comments to CNBC about the need for a third shot. The anchors also discussed the latest developments regarding companies' vaccine requirements and return to work plan revisions. U.S. Chamber of Commerce CEO Suzanne Clark joined the program to discuss the $1-trillion bipartisan bill passed by the Senate, labor shortages and what's at stake for corporate America. Also in focus: Market reaction to quarterly results from the likes of Airbnb and DoorDash, an update on the railroad bidding war over Kansas City Southern, a rough week for the chip stocks, and why FTC Chair Lina Khan is saying antitrust regulators should take a tougher approach when it comes to defense industry mergers.

On this week's "Face the Nation," the Delta variant is surging, what should teachers, students and parents expect as they head back to school this fall? Guest Moderator John Dickerson is joined by Education Secretary Miguel Cardona and Arkansas Governor Asa Hutchinson. Miami-Dade superintendent Alberto M. Carvalho weighs in on the controversy surrounding Florida Governor Ron DeSantis' order banning masks in schools. We'll hear from former FDA Commissioner Dr. Scott Gottlieb with the latest on the COVID19 pandemic. Plus, author explains the concept of high conflict. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's "Face the Nation," concerns over the highly contagious Delta Variant, and the CDC reversal of mask mandates. Guest Moderator John Dickerson is joined by White House Chief Medical Adviser and NIAID Director Dr. Anthony Fauci and former FDA Commissioner Dr. Scott Gottlieb. Meanwhile, Israel has officially started its COVID19 booster campaign for adults over 60, after data showed waning vaccine efficacy. What can the country's vaccine rollout teach us? We'll hear from Israel's Director of Public Health Services Dr. Sharon Alroy-Preis. How do coronvairus spikes fueled by the Delta Variant change our economic outlook? What can we expect to happen when the handful of remaining federal COVID support programs expire? Minneapolis Fed President Neel Kashkari breaks it all down. Plus, West Virginia Senator Joe Manchin will join us to discuss the next steps for infrastructure legislation and the latest on efforts to protect to voting rights.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Covid Delta variant is likely infecting more people than are being recorded, according to former FDA Commissioner Dr. Scott Gottlieb. He discusses transmission and hospitalization rates and responds to concerning data from an internal CDC presentation obtained by The Washington Post. Spirit Airlines CEO Ted Christie considers what the variant data means for leisure travel, and explains why he hasn't required vaccinations for his own employees or passengers. Scarlett Johansson and Disney are at odds after “Black Widow'' was released in theatres and on Disney+ on the same day. The actor claims the simultaneous push breached her contract, and Disney has fired back at the lawsuit. Plus, in the wake of Robinhood's public debut, the stock hasn't quite lived up to its promise--at least, not yet.

With stocks having finished Friday's session at record closing highs, Carl Quintanilla and Jim Cramer looked at what to expect from the markets as we enter a big week full of earnings reports, with mega-cap tech names Apple, Amazon, Microsoft, Facebook and Alphabet leading the pack. U.S.-China talks on the front burner as a Beijing official blamed the Americans for a "stalemate" in relations -- while stocks of China-based companies take another hit as Beijing ramps up its regulatory crackdown on technology and education firms. Cramer says China is engaging in an "attack on the rich" and says "you don't want your money there, you want your money here" in the U.S. The reopening trade and continuing spread of the COVID-19 Delta variant also in the spotlight. The anchors reacted to what former FDA Commissioner Dr. Scott Gottlieb told CNBC about the variant: He explained why he believes Delta could "plateau here in the United States" in the next two to three weeks. Carl and Jim also discussed a note out of Goldman Sachs Chief U.S. Equity Strategist David Kostin in which he sees the variant posing a "minimal risk to the U.S. equity markets." The anchors had lots of crypto news to highlight: A published report says a U.S. probe into Tether is homing in on whether executives behind the digital token committed bank fraud. Separately, Bitcoin hit a new six-week high and briefly passed $39,000 over the weekend -- with crypto rallying across the board, due in part to a report stating that Amazon is moving toward accepting Bitcoin for payment and is also considering the creation of its own digital token. Also in focus: Tesla as a China proxy ahead of its after-the-bell earnings report, Hasbro surging on better-than-expected quarterly results, and Norwegian Cruise Line sets sail for the first time since suspending cruising 500 days ago due to the pandemic.

The Delta variant is driving the U.S. into a fourth wave of the COVID-19 pandemic. Mark Strassmann reports that as cases spike across the country, vaccination rates will define the next phase of the virus. We'll hear from former FDA Commissioner Dr. Scott Gottlieb and former U.S. Surgeon General Dr. Jerome Adams about the risk this poses for everyone -- vaccinated and unvaccinated. Plus, interviews with Secretary of Commerce Gina Raimondo, Kansas City Mayor Quinton Lucas, and Washington Post's Carol Leonnig on new book about former President Trump. John Dickerson guest-moderates this week's "Face the Nation."See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jim Cramer and David Faber began the new trading week with an in-depth look at the market sell-off, as investors focus on the spreading of the COVID-19 Delta Variant and the rate of vaccinations falling. The reopening trade -- including cruise line and airline stocks -- taking a hit, while the 10-year note yield falls to fresh five-month lows. Cramer explains why be believes the FAANG stocks are the key to this market: "Once FAANG has rolled over, then you can buy." Jim and David reacted to President Biden's "They're killing people" comment that slammed Facebook and social media for their handling of vaccine disinformation on their platforms -- and Facebook striking back at the White House with a response. The anchors also discussed former FDA Commissioner Dr. Scott Gottlieb telling CNBC that Facebook must do more to control misinformation. On the M&A and "stay-at-home" stocks front, the anchors discussed Zoom Video's biggest-ever acquisition: The company agreeing to buy cloud-based call center operator "Five9" in a $14.7-billion all-stock deal. On the flip side, billionaire investor Bill Ackman's "Pershing Square Tontine Holdings" SPAC dropped plans to buy a 10% stake in Vivendi's Universal Music Group worth $4-billion. Instead, Ackman plans to acquire the stake through his Pershing Square hedge fund. The anchors reacted to Ackman telling CNBC the SEC's view of the deal was a "dagger in the heart of the transaction." New details about Robinhood's upcoming IPO: In a regulatory filing, the trading platform says it anticipates offering 55 million shares at a price between $38 and $42 per share -- aiming for a valuation of up to $35-billion. Also in focus: Duke Energy's management under scrutiny from hedge fund Elliott Management, plus Dish Network and AT&T enter into a ten-year network services deal.

On this week's "Face the Nation," COVID-19 cases are spiking across the country and consumer prices are also on the rise. Guest moderator John Dickerson is joined by former FDA Commissioner Dr. Scott Gottlieb to discuss the Delta variant. CBS News Business Analyst Jill Schlesinger on inflation, David Becker, the executive director for the Center for Election Innovation and Research about election laws, Plus, interviews with Chris Krebs, and former Chairman of the Joint Chiefs of Staff Adm. Michael Mullen. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Is the U.S. facing another surge of COVID-19? We hear from Dr. Anthony Fauci, and former FDA Commissioner Dr. Scott Gottlieb about how the Delta variant will affect the road to recovery. Meanwhile, as U.S. troops withdraw from Afghanistan, ending America's longest war, the stability of the region remains uncertain. Charlie D'Agata reports from Kabul on the potential threat to Afghans posed by the Taliban. Former Homeland Security Secretary Jeh Johnson weighs in on how to handle a new era of cyber threats and what comes next as the US exits Afghanistan. Coast-to-coast, the country is facing extreme weather. While the East Coast is plagued by severe storms, the west is getting hotter. Mark Strassmann reports from Las Cruces, New Mexico on record-breaking triple-digit temperatures. Plus, United Airlines CEO Scott Kirby joins to discuss the future of the airline industry. John Dickerson moderates this week's "Face the Nation." See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Disruptor investing app Robinhood has finally filed to IPO after years of upending the retail trading industry and months of regulatory and legal scrutiny. Founder and managing partner of venture capital firm Bedrock Capital Geoff Lewis shares his outlook for the company, its roadshow, and all the investors who want a piece. Virgin Galactic founder Sir Richard Branson is headed to space, just days before his fellow billionaire, Amazon founder Jeff Bezos, was scheduled to lift off himself. CNBC.com space reporter Michael Sheetz discusses the billionaire race to the edge of space. As millions hit the roads and runways across the country ahead of the July 4th holiday, former FDA Commissioner Dr. Scott Gottlieb considers risks of the Covid-19 Delta variant. Plus, the price of oil is nearing three-year-high, and OPEC+ is meeting to determine a global energy policy. Happy Independence Day!

On this week's "Face the Nation," tragedy in Miami: What caused the building to collapse? Mark Strassmann is in Surfside, Florida, with the latest on the search and rescue efforts. Guest Moderator John Dickerson talks to Miami-Dade County Mayor Daniella Levine Cava, Miami Mayor Francis Suarez and Senator Marco Rubio (R-FL.) We'll hear from White House Senior Adviser Cedric Richmond and Senator Jon Tester (D-MT) about an infrastructure deal. With the Delta Variant gaining a foothold in under-vaccinated areas, Arkansas Governor Asa Hutchinson talks with us about his state's COVID19 vaccine push, and former FDA Commissioner Dr. Scott Gottlieb breaks down the implications of our slowing vaccine drive.Privacy Policy and California Privacy Notice.

On this week's "Face the Nation," the digital age Cold War, Russian and the rising threat of cyber crime. Guest Moderator John Dickerson speaks with House Intel Chair Rep. Adam Schiff and Russia expert Fiona Hill. This past week, President Biden declared Juneteenth, the day enslaved Blacks in Texas learned they were free, a federal holiday. We hear from Smithsonian Secretary Lonnie Bunch about the newest page in history. Plus, former FDA Commissioner Dr. Scott Gottlieb and author Daniel Pink on the post-COVID road to recovery.

On this week's "Face the Nation," American leadership is back in focus on the international stage as President Biden meets with western leaders. What's at stake as he prepares to come face-to-face with Russian President Vladimir Putin? Moderator John Dickerson is joined by Secretary of State Antony Blinken, to talk about America's return to diplomacy; Senator Susan Collins (R-ME) who is part of a bipartisan group of senators working on an infrastructure bill, former FDA Commissioner Dr. Scott Gottlieb and Former White House Senior Adviser for COVID Response with the latest on the coronavirus.

On this week's "Face the Nation," we hear from Miami Police Chief Art Acevedo about the next chapter of police reform. This comes after the one year anniversary of George Floyd's death. Will the CDC’s new relaxed mask guidelines for summer camps help get more kids back to camp? We hear from former FDA Commissioner Dr. Scott Gottlieb YMCA CEO Kevin Wash. With US travel reaching pandemic highs and much of Europe preparing to open doors to vaccinated travelers, Trip Advisor CEO Stephen Kaufer breaks down the beginnings of a travel rebound. Meanwhile, 1.8 billion vaccine doses have been given worldwide, and infections are declining in global COVID-19 hotspots like Brazil and India, but the World Health Organization warns the pandemic isn’t over yet. CBS News’ Elizabeth Palmer reports. Finally, is Americans' mental health recovering at the same pace as the country's return to normal? We hear from President and CEO, Mental Health America Paul Gionfriddo.

Space tourism company Virgin Galactic logged a successful spaceflight test over the weekend, complete with flips in microgravity and a stock surge to match. Offices are ready to return to normal, and staffing agency Lasalle Network CEO Tom Gimbel says the “new” normal will likely look a lot like the old one. He shares his expectations for hybrid work, as well as the pros and cons of remote work for employees and managers alike. The U.S. may finally be turning a corner in the pandemic; former FDA Commissioner Dr. Scott Gottlieb discusses masking for kids, the Covid-19 origin story, and the likelihood of a winter resurgence. Plus, cryptocurrencies are emerging from a hell week, and Phil Mickelson has won the PGA Championship, a victory that makes him the oldest major champion in golf history.

In a surprise move, AT&T has announced a $43 billion deal to merge WarnerMedia with Discovery Inc. Joe, Becky, and Andrew digest the news and what it means for media, from Hollywood to Wall Street. Media watcher and LightShed Partners co-founder Richard Greenfield considers content and business possibilities for the new entity and explains how he sees the deal affecting HBO Max and Discovery Plus subscribers. Plus, the “new” normal is finally on its way: former FDA Commissioner Dr. Scott Gottlieb says that by June, most Americans won’t be wearing masks, and vaccinated people have very little reason to continue wearing them.

In an exclusive interview, NIAID Director Dr. Anthony Fauci talks about the new guidance for the fully vaccinated, and the next front in the fight against COVID-19. We'll also here from former FDA Commissioner Dr. Scott Gottlieb. We'll have an exclusive interview with Israeli PM Benjamin Netanyahu amid increasing violence in the region. After a cyberattack on the Colonial Pipeline reveals glaring vulnerabilities in America's critical infrastructure, how do we strengthen our defenses? We hear from former Cybersecurity and Infrastructure Security Agency Director Chris Krebs and Intelligence Committee Chairman Adam Schiff. Plus, Senators Joni Ernst and Kirsten Gillibrand tell us about their breakthrough in the push to reform the way America's military handles sexual assault cases. John Dickerson guest-moderates this week's "Face the Nation."

Following a disappointing April jobs report, what's next for the U.S economy? "Face the Nation" guest moderator John Dickerson talks to Commerce Secretary Gina Raimondo and Minneapolis Fed President Neel Kashkari. We'll also hear from Rep. Adam Kinzinger (R-IL) about the GOP's plan to strip Representative Liz Cheney, chair of the House Republican Conference, of her post over her frequent criticism of former President Trump. Plus, the latest on the coronavirus with former FDA Commissioner Dr. Scott Gottlieb, CBS's Chris Livesay, who reports from India, where COVID19 deaths continue to rise, and author Michael Lewis, author of the book, "The Premonition: A Pandemic Story."

On this week's "Face the Nation," with guest moderator John Dickerson, we hear from White House Chief of State, Ronald Klaine. South Carolina Senator, Tim Scott, who gave the Republican response to President Biden address to Congress. Plus the latest on the coronavirus pandemic with former FDA Commissioner Dr. Scott Gottlieb, and a focus group on President Biden first 100 days in office.

In the wake of the Derek Chauvin verdict, calls for racial justice nationwide have been renewed once more. CBS News senior national correspondent Mark Strassmann reports on the ongoing efforts to provide police reforms in a climate of tension. Meanwhile, Ohio Governor Mike Dewine breaks down ongoing proposals he's put forth in Ohio to address policing in his state. This comes after the officer involved shooting of Ma'Khia Bryant. We'll also hear from Houston, Texas Police Chief Troy Finner, Florida and former Orlando Police Chief Rep. Val Demings, and NAACP Legal Defense Fund President Sherrilyn Ifill. CBS News Elections and Surveys Director Anthony Salvanto has a new poll on what Americans feel about Chauvin verdict and more. Plus, the latest on the coronavirus pandemic with former FDA Commissioner Dr. Scott Gottlieb. John Dickerson guest-moderates this week's "Face the Nation."

Former FDA Acting Chief Scientist Dr. Luciana Borio and former FDA Commissioner Dr. Scott Gottlieb on the CDC's latest guidance for vaccinated Americans, if and when to vaccinate children, and how things return to normal.

Ryan Gorman hosts an iHeartRadio nationwide special featuring FDA Commissioner Dr. Stephen Hahn on the science behind COVID-19 vaccines and distribution plans. Also, iHeartRadio reporter Al Lews talks to the head of the Community Interventions & Critical Populations Task Force about coronavirus guidance heading into the final stretch of this holiday season. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.

After a day of celebration and heartache, Americans face a harsh reality with the Covid-19 crisis.A record 112,816 Covid-19 patients were hospitalised Tuesday, according to the Covid Tracking Project.That will inevitably lead to more deaths as Christmas and New Year's Day get closer.And while more doses of the Pfizer/BioNTech vaccine are sent across the country this week, there won't be enough for everyone who wants it for months."This vaccine, as wonderful as it is, is not going to change the trajectory of what we experience this winter," said Dr. Richard Besser, former acting director of the US Centers for Disease Control and Prevention."It's not going to change what we need to do. It's not going change the need for us all to wear masks, and social distance and wash our hands."The FDA authorises a fully at-home testThe US Food and Drug Administration gave emergency authorisation Tuesday for the first Covid-19 test that can be fully taken at home.Other at-home tests require a prescription or require people to send test samples to a lab to get results. But the Covid-19 home test developed by Australian company Ellume is sold over-the-counter and produces results that can be read at home."Today's authorization is a major milestone in diagnostic testing for COVID-19," FDA Commissioner Dr. Stephen Hahn said in a written statement. "By authorizing a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes."The test uses an analyzer that connects with a software application on a smartphone to help users perform the test and interpret results, the FDA said.The Ellume test is an antigen test that "correctly identified 96% of positive samples and 100% of negative samples in individuals with symptoms," the FDA said.In people without symptoms, the test correctly identified 91% of positive samples and 96% of negative samples, the FDA said.Because the test isn't perfect, people who get a negative result should still presume they may be infected and act accordingly -- wearing a mask and keeping away from others.Ellume expects to produce more than 3 million tests in January. When it applied for emergency use authorization, the company said it would charge $30 for the test.Text by CNN

First, Jake presses FDA Commissioner Dr. Stephen Hahn on if the Trump administration politicized the vaccine approval process. Then, Jake talks with Microsoft co-founder Bill Gates on the US response to the coronavirus pandemic. Next, former Vice President Al Gore joins Jake to reflect on his decision to concede the 2000 election 20 years later. Then, Jake asks Louisiana Sen. Bill Cassidy if he thinks the Senate will be able to approve a bipartisan coronavirus relief bill by the end of the year. Next, Jake asks former Georgia gubernatorial candidate Stacey Abrams about Democrats' efforts to flip Georgia's Senate seats in the January runoff election. Finally, Jake looks at the ways the Trump presidency exposed major issues with America's political system. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

 US Covid-19 hospitalizations hit a record high for the seventh day in a row Saturday with 108,487 patients in hospitals around the country, according to the Covid Tracking Project.And the number of Covid-19 cases reported in the United States reached more than 16 million after the country added 1 million cases in just four days, according to Johns Hopkins University data.It took the nation more than eight months to reach 8 million cases but less than two months to double that, as the number of new cases continues to soar.The record hospitalizations come as a US Centers for Disease Control and Prevention advisory committee voted Saturday to recommend the Pfizer and BioNTech Covid-19 vaccine for patients 16 and older.CDC Director Dr. Robert Redfield must accept the Advisory Committee on Immunization Practices' (ACIP) recommendation before vaccinations can begin. That is expected to happen within hours.The vaccine couldn't come at a more dire moment.On Friday, as the US Food and Drug Administration authorized the Pfizer vaccine for emergency use, the US recorded more than 3,300 Covid-19 deaths -- the most ever in one day, according to data from Johns Hopkins University. More than 231,700 new cases were reported, another pandemic high.There have been more than 100,000 Covid-19 patients in hospitals every day since December 2.Dr. Peter Szilagyi, a pediatrician at the University of California Los Angeles and a member of the CDC's advisory committee, said he voted in favor of the vaccine "because of the clear evidence of its efficacy/safety profile and benefit/risk profile, based on our evidence and policy framework.""I know we're going to have very tough and hard times ahead because of the surge and a limited vaccine supply," Szilagyi said immediately following the committee's vote. "But I am really hopeful that this is the beginning of the end of the coronavirus pandemic."Vaccines will be delivered to 145 facilities on MondayThe emergency use authorization (EUA) is a "significant milestone," FDA Commissioner Dr. Stephen Hahn said in a statement Friday. He said it comes after an "open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists."An EUA stops short of a full approval. Pfizer would have to file a separate application for its vaccine to be fully licensed by the FDA.But the EUA "holds the promise to alter the course of this pandemic in the United States," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.Once the vaccines leave Pfizer's Kalamazoo facility, they'll be bound for 636 locations across the country, Gen. Gustave Perna, chief operating officer of the federal government's vaccine initiative Operation Warp Speed, said in a news conference Saturday."We expect 145 sites across all the states to receive the vaccine on Monday, another 425 sites on Tuesday, and the final 66 sites on Wednesday, which will complete the initial delivery of the Pfizer orders for the vaccine," Perna added.But it will be months before most Americans will get one. Advisers to the CDC have recommended health care workers and long-term care facility residents be first in line.In a news conference Saturday morning, Hahn praised FDA scientists working around the clock to review the vaccine."I will absolutely take this Covid-19 vaccine pending availability and distribution," he said, "because I have complete trust and confidence in the FDA's career staff's evaluation.""Science and data guided the FDA's decision," he said.That said, the FDA's "work evaluating the Pfizer-BioNTech vaccine does not end with this authorization," Hahn told reporters.Additional review is needed, and a full approval is not expected for months.Of course, Pfizer and BioNTech's vaccine is just one of those in development. Health and Human Services Secretary Alex Azar told ABC News on Friday that about...

On this episode of the Breakdown with Senator James Lankford, Senator Lankford goes in depth with the FDA Commissioner Dr. Stephen Hahn to discuss the latest news surrounding the science behind the Covid-19 vaccine.